Colmenar Viejo, Madrid, Spain

Andres M Francesch Solloso

This inventor holds 1 USPTO granted patent. Top assignee: Pharma Mar, S.a.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andres M Francesch Solloso. Retrieved from https://idiyas.com/inventor/andres-m-francesch-solloso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Andres M Francesch Solloso

Introduction

Andres M Francesch Solloso is a notable inventor based in Colmenar Viejo, Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody drug conjugates. His work is instrumental in advancing medical treatments and therapies.

Latest Patents

Francesch Solloso holds a patent for "Antibody Drug Conjugates Comprising Ecteinascidin Derivatives." This innovative patent highlights his expertise in creating targeted therapies that can improve patient outcomes in various medical conditions. He has 1 patent to his name, showcasing his commitment to innovation in the pharmaceutical industry.

Career Highlights

Francesch Solloso is currently employed at Pharma Mar, S.A., a leading biopharmaceutical company known for its focus on oncology and rare diseases. His role at Pharma Mar allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Throughout his career, Francesch Solloso has worked alongside talented colleagues, including Maria Del Carmen Cuevas Marchante and Alfonso Latorre Lozano. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Andres M Francesch Solloso exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of antibody drug conjugates, reflect his dedication to improving healthcare through scientific advancements. His work continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…